Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Processa Pharmaceuticals (PCSA)

Processa Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PCSA
DateTimeSourceHeadlineSymbolCompany
06/09/202313:15GlobeNewswire Inc.Processa Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:PCSAProcessa Pharmaceuticals Inc
17/08/202317:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
17/08/202313:05GlobeNewswire Inc.Processa Pharmaceuticals Provides Data Update Supporting a Potential Personalized Treatment Approach for Improved Cancer CareNASDAQ:PCSAProcessa Pharmaceuticals Inc
10/08/202321:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PCSAProcessa Pharmaceuticals Inc
10/08/202321:15GlobeNewswire Inc.Processa Pharmaceuticals to Present at the Sidoti & Co. Micro Cap Virtual ConferenceNASDAQ:PCSAProcessa Pharmaceuticals Inc
09/08/202321:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCSAProcessa Pharmaceuticals Inc
09/08/202321:47Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PCSAProcessa Pharmaceuticals Inc
08/08/202315:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
08/08/202313:15GlobeNewswire Inc.Processa Pharmaceuticals Appoints Life Sciences Industry Veteran George Ng as Chief Executive OfficerNASDAQ:PCSAProcessa Pharmaceuticals Inc
24/07/202323:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCSAProcessa Pharmaceuticals Inc
24/07/202323:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCSAProcessa Pharmaceuticals Inc
24/07/202323:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCSAProcessa Pharmaceuticals Inc
29/06/202321:19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCSAProcessa Pharmaceuticals Inc
29/06/202321:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
14/06/202321:15GlobeNewswire Inc.Next Generation Chemotherapy: Improved Treatment for More PatientsNASDAQ:PCSAProcessa Pharmaceuticals Inc
12/06/202321:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
24/05/202319:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCSAProcessa Pharmaceuticals Inc
22/05/202313:05GlobeNewswire Inc.Processa Pharmaceuticals to Participate in a Panel on Interaction with the FDA at the World Orphan Drug CongressNASDAQ:PCSAProcessa Pharmaceuticals Inc
18/05/202320:25Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCSAProcessa Pharmaceuticals Inc
18/05/202313:00GlobeNewswire Inc.Processa Pharmaceuticals to Conduct Next Generation Chemotherapy-Capecitabine Phase 2 Trial Based on FDA Guidance and Project Optimus Oncology InitiativeNASDAQ:PCSAProcessa Pharmaceuticals Inc
15/05/202315:03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PCSAProcessa Pharmaceuticals Inc
01/05/202315:03Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:PCSAProcessa Pharmaceuticals Inc
01/05/202315:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PCSAProcessa Pharmaceuticals Inc
01/05/202315:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PCSAProcessa Pharmaceuticals Inc
28/04/202313:15GlobeNewswire Inc.Processa Pharmaceuticals to Present PCS12852 Gastroparesis Results at the Digestive Disease Week 2023 Annual MeetingNASDAQ:PCSAProcessa Pharmaceuticals Inc
14/04/202321:31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:PCSAProcessa Pharmaceuticals Inc
31/03/202313:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCSAProcessa Pharmaceuticals Inc
30/03/202321:10Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PCSAProcessa Pharmaceuticals Inc
30/03/202321:01GlobeNewswire Inc.Processa Pharmaceuticals Provides Corporate Update and Announces Year End 2022 Financial ResultsNASDAQ:PCSAProcessa Pharmaceuticals Inc
23/03/202312:30GlobeNewswire Inc.Processa Pharmaceuticals to Host Conference Call to Discuss 2022 Year End Results and Provide Drug Development Update on March 30, 2023 at 4:30 p.m. ESTNASDAQ:PCSAProcessa Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PCSA

Your Recent History